Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06670378Active Not Recruiting

Natural History Study for Patients With Nemaline Myopathy in the UK

Role: collaborator

NCT04064307Recruiting

Myotubular and Centronuclear Myopathy Patient Registry

Role: collaborator

NCT06711692Not Yet Recruiting

The U.K. NorthStar Clinical Network

Role: collaborator

All 3 trials loaded